Clinical trial
A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients…
NCT00196872 · GBG Forschungs GmbH, Other · Completed
Key facts
| NCT number | NCT00196872 |
|---|---|
| Title | A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN) |
| Official title | A Phase III Trial to Compare ETC vs, EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN) |
| Lead sponsor | GBG Forschungs GmbH, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Epirubicine, Cyclophosphamide, Taxol, Xeloda, Ibandronat |
| Enrollment | 3,000 |
| Start date | Jul 1, 2004 |
| Primary completion | Jun 1, 2014 |
| Completion | Jun 1, 2014 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 17, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: